| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8827990 | European Urology Focus | 2017 | 17 Pages |
Abstract
PET/CT and whole-body MRI scans have the potential to improve detection and to assess response to treatment of all states of advanced prostate cancer. Consensus recommendations on quality standards, interpretation, and reporting are needed but will require validation in clinical trials of established and new treatment approaches.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Urology
Authors
Anwar R. Padhani, Frederic E. Lecouvet, Nina Tunariu, Dow-Mu Koh, Frederik De Keyzer, David J. Collins, Evis Sala, Stefano Fanti, H. Alberto Vargas, Giuseppe Petralia, Heinz Peter Schlemmer, Bertrand Tombal, Johann de Bono,